VET.TOVET.TOTSX
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -4.22% | -0.06% | +17.53% | +2.46% | -16.34% |
| Gross Profit Growth | -71.75% | +403.82% | +277.77% | +184.76% | +201.29% |
| EBITDA Growth | +12.41% | +0.00% | -12.13% | +126.29% | -8.04% |
| Operating Income Growth | -39.60% | +159.39% | +81.33% | -13.47% | +311.76% |
| Net Income Growth | -9.79% | +0.00% | +548.72% | +0.00% | -95.05% |
| EPS Growth | -5.71% | +0.00% | +578.32% | +0.00% | -109.36% |
| EPS Diluted Growth | -2.94% | +0.00% | +581.56% | +0.00% | -109.42% |
| Weighted Average Shares Growth | -4.47% | -3.36% | -4.37% | -3.25% | -1.46% |
| Weighted Average Shares Diluted Growth | -5.34% | -3.36% | -4.91% | -2.35% | -1.64% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +13.60% | -38.17% | -20.86% | -47.26% | +189.45% |
| Free Cash Flow Growth | +0.00% | -96.64% | -39.89% | -84.00% | +1986.83% |
| Receivables Growth | -9.07% | +22.87% | -12.07% | +15.91% | -31.44% |
| Inventory Growth | +8.18% | -29.02% | +49.84% | +38.62% | +55.40% |
| Asset Growth | -15.04% | -1.93% | +12.00% | +8.50% | -2.15% |
| Book Value per Share Growth | -21.78% | -4.05% | +1.03% | -1.64% | -4.53% |
| Debt Growth | +2.18% | +5.20% | +100.63% | +93.30% | +29.28% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +3.27% | +26.29% | +38.91% | -16.53% | -11.52% |